Table 4 Summary of pathogenic potential, functional alteration, and genotype of genes in epileptic encephalopathies

From: Evaluating the pathogenic potential of genes with de novo variants in epileptic encephalopathies

 

Pathogenic

Possibly pathogenic

To be confirmed

GOF (missense)

Ion channel

  

KCNA2, KCNT1; GRIN2A, GRIN2B

SCN2A, SCN8A; GRIN2D

KCNQ2; HCN1

Non-ion channel

  

FGF12

  

LOF or destructive

Ion channel

  

SCN1A; KCNA2a, KCNB1, KCNQ2; GABRG2a; GRIN1a

SCN2A; GABRA1, GABRB1a, GABRB2a, GABRB3; GRIN2Aa; HCN1a

SCN8A; GRIN2B

Non-ion channel

  

CHD2, DNM1a, GNAO1, SLC6A1, SPTAN1, STXBP1

ANKRD11, DNM1La, SLC2A1, SYNGAP1

DYRK1A, HNRNPU, KMT2A, NUS1, TRIM8, ZEB2

X-linked

  

CASK, CDKL5, CLCN4a, DCX, IQSEC2, PCDH19b, SLC35A2, WDR45

MECP2, SLC9A6

SMC1A

UD

 

ALG13, ATP1A2, CACNA1A, DYNC1H1, EEF1A2, FOXG1, HECW2, KCNA1, NACC1, NEDD4L, NTRK2, PIGA, YWHAG

BCL11A, CLTC, COL4A1, DHDDS, FASN, GABBR2, MEF2C, NAA10, NR2F1, PIK3AP1, RANGAP1, RYR3, SIK1, SLC1A2, SNAP25, TBL1XR1

  1. Underline, gene with diverse functional alterations
  2. GOF gain of function, LOF loss of function, UD functional alteration not determined missense
  3. aGenes with variants of only missense that revealed a functional alteration of LOF
  4. bSpecial mechanism other than LOF and GOF